UBIQUITIN CONFERENCE

Ubiquitin Drug Discovery and Diagnostics 2009 (ARCHIVE)

Date: October 13, 2009 — 14 October 2009
Location: Park Hyatt at the Bellevue (Philadelphia)
The ubiquitin story has launched an exciting new enterprise in molecular medicine. The 2004 Nobel Prize in Chemistry was awarded to Dr. Aaron Ciechanover and colleagues for uncovering the ubiquitin pathway, which we now know plays a fundamental role in human physiology. Ubiquitin pathways offer drug discovery opportunities that will surpass those recently exploited in the protein kinase field, as evident in the recent approval of Velcade/bortezomib. The ubiquitin conference uniquely brings together academic and pharmaceutical industry leaders to explore novel ubiquitin-based therapeutics and diagnostics. The pre-conference workshop delineates state of the art assay development for primary ubiquitin drug targets -- ligases and deubiquitylases. The general meeting provides academic and pharmaceutical researchers a venue to present recent findings in ubiquitin-related therapeutics.  Approximately 30% of the submitted abstracts will be selected for podium presentation. Finally, the conference’s Ubiquitin Business Round Table affords a unique opportunity for industry and academia to develop collaborations and partnerships.
Read More & Register Online